PARATHYROID CYST

This adverse event was reported 26 times

PARATHYROID CYST is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 RILONACEPT 1 0.0009
1 ADALIMUMAB-AFZB 1 0.0004
2 LANTHANUM CARBONATE 1 0.0002
3 PARICALCITOL 2 0.0001
4 FEBUXOSTAT TABLETS 40 MG 1 0.0001
5 FEBUXOSTAT 1 0.0001
6 ALEMTUZUMAB 1 0.0001
7 CALCITRIOL CAPSULES 0.25 MCG 1 0.0000
8 CINACALCET HYDROCHLORIDE 2 0.0000
9 ZINC CHLORIDE 1 0.0000
See all drugs enriched for association with PARATHYROID CYST

PARATHYROID CYST is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Vitamin D2 Analog [EPC] 2 0.0003
1 Vitamin D Analog [EPC] 2 0.0001
2 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
3 Vitamin D3 Analog [EPC] 1 0.0000
4 Provitamin D2 Compound [EPC] 1 0.0000
5 beta3-Adrenergic Agonist [EPC] 1 0.0000
6 Calcium [EPC] 2 0.0000
7 Antirheumatic Agent [EPC] 1 0.0000
8 alpha-Adrenergic Blocker [EPC] 1 0.0000
9 GLP-1 Receptor Agonist [EPC] 3 0.0000
See all drug classes enriched for association with PARATHYROID CYST